Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of MitoQ10 on polycystic ovary syndrome
IRCT20171210037804N1Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of mitoquinone in polycystic ovary syndrome (PCOS), sponsored by Tehran University of Medical Sciences. Started Jan 2018; status: completed.
02
Drugs
mitoquinone
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20171210037804N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171210037804N1.